apollo
0
48 Hrs returnable
COD available

Online payment accepted

Prescription drug

Whats That

tooltip
IPILIMUMAB-5MG
PARENTERAL
Not Returnable
Apr-24
Prescription drug
 Trailing icon

Country of origin

Ireland
Other Info - YER0002

FAQs

Yervoi 5 mg/ml Infusion 10 ml contains Ipilimumab, which works by inhibiting the action of a human cytotoxic T-lymphocyte antigen-4 (CTLA-4) molecule that causes the multiplication of cancerous cells.
It is safe to use Yervoi 5 mg/ml Infusion 10 ml in patients with diabetes. However, if you are diabetic, inform your doctor before starting the treatment with Yervoi 5 mg/ml Infusion 10 ml.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
bannner image

Alcohol

Consult your doctor

It is unknown whether Yervoi 5 mg/ml Infusion 10 ml interacts with alcohol. Consult your doctor.

bannner image

Pregnancy

Unsafe

Yervoi 5 mg/ml Infusion 10 ml is not recommended for use in pregnancy as it may cause embryo-fetal toxicity and harm your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before taking Yervoi 5 mg/ml Infusion 10 ml. You should not become pregnant while you are taking Yervoi 5 mg/ml Infusion 10 ml for at least 3 months from the last dose of Yervoi 5 mg/ml Infusion 10 ml. Using effective birth control methods while on treatment with Yervoi 5 mg/ml Infusion 10 ml is suggested.

bannner image

Breast Feeding

Unsafe

Inform your doctor if you are intending to breastfeed. Breastfeeding should be avoided while getting Yervoi 5 mg/ml Infusion 10 ml and for 3 months following the final dosage.

bannner image

Driving

Not applicable

Yervoi 5 mg/ml Infusion 10 ml will be administered to hospitalized patients.

bannner image

Liver

Caution

If you have a pre-existing or a history of liver problems, tell your doctor before taking this medicine. Yervoi 5 mg/ml Infusion 10 ml is known to cause hepatotoxicity when taken in combination with nivolumab. Notify your doctor if you notice any of the following symptoms: yellowing of your skin or whites of your eyes; severe nausea or vomiting; pain on the right side of your stomach (abdomen); dark urine (tea-coloured); easier bleeding or bruising than usual. Your doctor may suggest tests to monitor your liver function while on treatment with this medicine.

bannner image

Kidney

Caution

If you have a pre-existing or a history of kidney diseases, inform your doctor before taking Yervoi 5 mg/ml Infusion 10 ml. It may cause kidney injury. Notify your doctor if you experience symptoms such as decreased urine output, blood in your urine, ankle edema, or lack of appetite.

bannner image

Children

Unsafe

Yervoi 5 mg/ml Infusion 10 ml is not recommended for use in children below 12 years, as the safety and efficacy have not been established.

icon image

Keep Refrigerated. Do not freeze.Prepaid payment required.

About Yervoi 5 mg/ml Infusion 10 ml

Yervoi 5 mg/ml Infusion 10 ml is an anti-cancer medicine used in the treatment of various types of cancers. Cancer is a disease caused by the abnormal growth of cells that divide uncontrollably. This medicine is used in treating metastatic melanoma, advanced renal cell carcinoma in combination with nivolumab, hepatocellular carcinoma in patients who have previously been treated with sorafenib, colorectal cancer, metastatic non-small cell lung cancer, and malignant pleural mesothelioma.

Yervoi 5 mg/ml Infusion 10 ml contains Ipilimumab, which belongs to the class of CTLA-4 monoclonal antibody. It works by inhibiting the action of a human cytotoxic T-lymphocyte antigen 4 molecule, thereby stopping the abnormal growth of cancer cells.

Yervoi 5 mg/ml Infusion 10 ml may cause certain side effects such as diarrhoea, decreased appetite, nausea, vomiting, tiredness, itching, rash, headache, fever, decreased weight, and dizziness. Inform your doctor if any of these side effects bother you. Yervoi 5 mg/ml Infusion 10 ml will be administered by an oncologist with experience in administering chemotherapeutic agents in the hospital setting. Avoid self-administration.

If you are allergic to Yervoi 5 mg/ml Infusion 10 ml or its components, inform your doctor. Before taking Yervoi 5 mg/ml Infusion 10 ml, inform your doctor if you have/had liver or kidney disease, autoimmune disorders such as ulcerative colitis, Crohn’s disease, or a history of organ transplants. This medicine is known to cause embryo-fetal toxicity. Hence, it is not recommended for use in pregnancy. If you are breastfeeding, inform your doctor before receiving Yervoi 5 mg/ml Infusion 10 ml.

Uses of Yervoi 5 mg/ml Infusion 10 ml

Renal Cell Carcinoma, Hepatocellular carcinoma, Colorectal Cancer, Metastatic Melanoma, metastatic non-small cell lung cancer, Malignant pleural mesothelioma.

Medicinal Benefits Mweb

Medicinal Benefits

Yervoi 5 mg/ml Infusion 10 ml contains Ipilimumab, which is used in treating different types of cancers. It works by inhibiting the action of a human cytotoxic T-lymphocyte antigen 4 molecule (CTLA-4) that causes the multiplication of cancerous cells. This helps stop the abnormal growth of cancer cells and thus reduce the further spread to other parts of the body. In this way, Yervoi 5 mg/ml Infusion 10 ml stops the body's production, spread and growth of cancerous cells.

Directions for Use

Yervoi 5 mg/ml Infusion 10 ml will be administered by an oncologist with experience in administering chemotherapeutic agents in the hospital setting. Hence, do not self-administer. Your doctor will decide the dose and duration of the medicine based on the severity and type of cancer.

Side Effects of Yervoi 5 mg/ml Infusion 10 ml

  • Nausea
  • Vomiting
  • Diarrhoea
  • Loss of appetite
  • Tiredness
  • Chest pain
  • Dizziness
  • Weakness
  • Difficulty falling a sleep
  • Muscle pain
  • Cough
  • Headache
  • Fever
  • Itching
  • Rash

Drug Warnings

To treat your condition effectually, continue taking Yervoi 5 mg/ml Infusion 10 ml for the period that your doctor has prescribed. Yervoi 5 mg/ml Infusion 10 ml may cause severe immune-mediated adverse reactions (IMAR) such as immune-mediated colitis, hepatitis, nephritis, endocrinopathies, pneumonitis, and dermatologic reactions. It may also cause infusion-related reactions in some patients. Discontinue the treatment if any severe infusion reactions occur. Inform your doctor if you are pregnant or are planning to become pregnant before starting the treatment, as this medicine is known to cause embryo-fetal toxicity. Caution should be exercised if you have/had liver or kidney disease, any history of organ transplant, gastrointestinal disorders and autoimmune disorders such as ulcerative colitis or Crohn’s disease while receiving Yervoi 5 mg/ml Infusion 10 ml. Breastfeeding should be discontinued in nursing mothers during the treatment as it passes into breast milk and may cause a possible risk to the infant. This medicine is not recommended for use in children below 12 years of age as the safety and efficacy are not established. 

Drug-Drug Interactions

verifiedApollotooltip
IpilimumabFondaparinux
Severe
IpilimumabApixaban
Severe

Drug-Food Interactions

verifiedApollotooltip
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.

Drug-Diseases Interactions

verifiedApollotooltip
No Drug - Disease interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.

Drug-Drug Interactions Checker List

  • RIVAROXABAN
  • WARFARIN
  • HEPARIN
  • TERIFLUNOMIDE
  • ADO TRASTUZUMAB EMTANSINE
  • PEXIDARTINIB

Habit Forming

No

Special Advise

  • Your doctor may suggest periodic liver function tests, kidney function tests, and lung function tests to monitor the function of the liver, kidney and lungs due to the use of Yervoi 5 mg/ml Infusion 10 ml.
  • Using contraceptive pills while using Yervoi 5 mg/ml Infusion 10 ml to prevent pregnancy is advised.
  • Thyroid function and adrenocorticotropic hormone levels will be monitored during treatment to avoid any life-threatening side effects.

Diet & Lifestyle Advise

  • Physical activity helps strengthen muscles, reduces fatigue, helps in weight loss, and gives strength. Gentle activities like 20-30 minutes of walking or swimming would be helpful.
  • Maintain a healthy weight by performing regular low-strain exercises and eating healthy food.
  • Getting adequate sleep as resting helps improve your health and mental ability and improves attention.
  • De-stress yourself by meditating, reading books, taking a warm bubble bath, or listening to soothing music.
  • Eat food rich in antioxidants such as berries, spinach, etc.
  • Foods containing fibre help in better digestion. These include beans, peas, lentils, whole grains, nuts, and seeds.
  • Avoid smoking and alcohol consumption.
  • Maintain a healthy weight.

Add to Cart